TransMedics Group (TMDX) Tops Q1 EPS by 44c ; Offers Guidance

TransMedics Group (NASDAQ: TMDX) reported Q1 EPS of $0.70, $0.44 better than the analyst estimate of $0.26. Revenue for the quarter came in at $143.5 million versus the consensus estimate of $123.66 million.

GUIDANCE:

TransMedics Group sees FY 2025 revenue of $565-585 million, versus the consensus of $540.5 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Texas Capital Securities Reiterates Buy Rating on Texas Pacific Land Trust (TPL)
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary